S. 127 · 118th Congress (2023–2025)
Pharmacy Benefit Manager Transparency Act of 2023
This bill generally prohibits pharmacy benefit managers (PBMs) from engaging in certain practices when managing the prescription drug benefits under a health insurance plan, including charging the plan a different amount than the PBM reimburses the pharmacy.
The bill also prohibits PBMs from arbitrarily, unfairly, or deceptively (1) clawing back reimbursement payments, or (2) increasing fees or lowering reimbursements to pharmacies to offset changes to federally funded health plans.
PBMs are not subject to these prohibitions if they (1) pass along 100% of any price concession or discount to the health plan, and (2) disclose specified costs, prices, reimbursements, fees, markups, discounts, and aggregate payments received with respect to their PBM services.
Further, PBMs must report annually to the Federal Trade Commission (FTC) certain information about payments received from health plans and fees charged to pharmacies.
The FTC and state attorneys general are authorized to enforce the provisions of the bill.
Show official title
A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReported by committee
This bill’s path
This is S. 127’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
Expired
- Sponsor
- Sen. Maria Cantwell (D-WA)
- Cosponsors
14 cosponsors
7 original · 7 later
10 R · 4 D
- Sen. Mike Braun (R-IN)· Original · Jan 26, 2023
- Sen. Shelley Moore Capito (R-WV)· Original · Jan 26, 2023
- Sen. Chuck Grassley (R-IA)· Original · Jan 26, 2023
- Sen. Cindy Hyde-Smith (R-MS)· Original · Jan 26, 2023
- Sen. Jerry Moran (R-KS)· Original · Jan 26, 2023
- Sen. Jon Tester (D-MT)· Original · Jan 26, 2023
- Sen. Thom Tillis (R-NC)· Original · Jan 26, 2023
- Sen. John Boozman (R-AR)· Later · Jan 31, 2023
- Sen. Peter Welch (D-VT)· Later · Mar 6, 2023
- Sen. Roger Marshall (R-KS)· Later · Mar 30, 2023
- Sen. Martin Heinrich (D-NM)· Later · May 2, 2023
- Sen. Joni Ernst (R-IA)· Later · May 4, 2023
- Sen. Mike Rounds (R-SD)· Later · Jul 19, 2023
- Sen. Jeanne Shaheen (D-NH)· Later · Nov 9, 2023
- Policy area
- Health
- Subjects
- Civil actions and liability
- Congressional oversight
- Government information and archives
- Government studies and investigations
- Health care costs and insurance
- Medical ethics
- Prescription drugs
- State and local government operations
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
▸ 3 committee actions · Jan 26, 2023 – Dec 13, 2023
Referred to committee
Read twice and referred to the Committee on Commerce, Science, and Transportation.
Sources
- Congress.gov action
- Senate
Ordered reported
Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably.
Sources
- Congress.gov action
- Senate
Reported by committee
Committee on Commerce, Science, and Transportation. Reported by Senator Cantwell with an amendment in the nature of a substitute. Without written report.
Sources
- Congress.gov action
- Senate
Expired
Introduced → Reported by committee → No further action before the 118th Congress ended.
Committees
- SenateCommerce, Science, and TransportationReferred Jan 26, 2023 · Markup Mar 22, 2023 · Reported Dec 13, 2023
Mar 22, 2023 · Meeting
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
Titles (2)
Pharmacy Benefit Manager Transparency Act of 2023
Display title, Short title · Introduced in Senate, Reported to Senate
A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes.
Official title · Introduced in Senate